Japanese company recalls two million needles in US

Wednesday, January 27, 2010

The Japanese company Nipro has voluntarily recalled two million needles in the US used for withdrawing blood and medicine injections, health officials said today.

The affected items are Huber needles, manufactured in Japan and distributed by Exelint International Corporation. The needles are intended to access ports placed under chronically ill patients' skin, for frequent access to veins.

According to the Food and Drug Administration (FDA), inspections of Nipro facilities last October revealed problems with the needles, which could allow parts of silicone in the port to be dislodged. 60%–72% of tested needles had that problem. In a conference call with reporters, FDA officials remarked that they were concerned the silicone could enter the bloodstream of a patient, although, to date, no harm from this has been reported.

"There are more than 2 million units impacted by this recall in distribution nationwide. Recalled needles were manufactured from January 2007 to August 2009," read a statement on the FDA's website. "[...] Hospitals, clinics and patients who have needles from these lists should immediately stop using these affected products and return any unused products to Exelint International Corporation."

"At this time, the FDA has not received any adverse event reports related to silicone foreign bodies released in patients from Huber needle coring [...] However, because it may be very difficult for clinicians to associate adverse patient outcomes with the use of defective Huber needles, there may be under-reporting of events," the statement continued.

Exelint has not yet issued a public statement about the report from the FDA.

Have an opinion on this story? Share it!

Sources

"Nipro recalls 2 mln medical needles in U.S." — Reuters, January 26, 2010
Saundra Young. "FDA recalls more than 2 million needles used in port implants" — CNN, January 26, 2010
"FDA Announces Class I Recall of Certain Infusion Set Needles" — Food and Drug Administration, January 26, 2010

Share this:

This page is archived, and is no longer publicly editable.

Articles presented on Wikinews reflect the specific time at which they were written and published, and do not attempt to encompass events or knowledge which occur or become known after their publication.

Got a correction? Add the template {{editprotected}} to the talk page along with your corrections, and it will be brought to the attention of the administrators.

Please note that due to our archival policy, we will not alter or update the content of articles that are archived, but will only accept requests to make grammatical and formatting corrections.

Note that some listed sources or external links may no longer be available online due to age.

This page is archived, and is no longer publicly editable.

Articles presented on Wikinews reflect the specific time at which they were written and published, and do not attempt to encompass events or knowledge which occur or become known after their publication.

Got a correction? Add the template {{editprotected}} to the talk page along with your corrections, and it will be brought to the attention of the administrators.

Please note that due to our archival policy, we will not alter or update the content of articles that are archived, but will only accept requests to make grammatical and formatting corrections.

Note that some listed sources or external links may no longer be available online due to age.